Last year, Harvard Bioscience Inc generated 78.26M USD for its biggest-performing segment, Instruments, equipment, software and accessories. The United States made the largest contribution, accounting for 38.97M USD last year. For the latest quarter, Harvard Bioscience Inc reported the revenue of 20.30M USD for the period ending 2026-06-30, which came from the top-performing segment, Instruments, equipment, software and accessories. United States contributed the highest revenue, at 10.50M USD.